Monthly Archives: May 2024

Community Pharmacy England has today released a national report confirming the severe impact of the worsening medicines supply situation on patients and community pharmacies across England. The Pharmacy Pressures Survey 2024: Medicines Supply Report sets out what pharmacy owners and their teams have told us about just how critical the situation has become. The report, which [...]

The post Medicines supply issues are a daily battle, Pressures Survey confirms appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules MSN/2024/051 Tier 3 high impact Date of issue: 8th May 2024 All strengths of Elvanse® capsules are now available and an improved level of supply will continue across the majority of Elvanse® and Elvanse Adult® presentations. There will [...]

The post Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Sulfadiazine silver (Flamazine®) 1% cream MSN/2024/052 Tier 2 – medium impact Date of issue: 8th May 2024 Flamazine® 1% cream 20g, 50g and 500g packs are out of stock until early August 2024 Flamazine® 1% cream 250g packs will be out [...]

The post Medicine Supply Notification: Sulfadiazine silver (Flamazine® ) 1% cream appeared first on Community Pharmacy England.

Hep C U Later has been commissioned by NHS England to provide resources to help encourage hepatitis C testing amongst patients, to provide information to the public and update knowledge amongst healthcare professionals and their teams. It is estimated that around 70,000 people in England may still be unaware of having a hepatitis C infection. The [...]

The post New resources to help eliminate hepatitis C appeared first on Community Pharmacy England.

Eli Lilly and Company (Lilly) in agreement with the Medicines and Healthcare product Regulatory Agency (MHRA) has announced an extension to the shelf-life of Mounjaro®▼ (tirzepatide) 2.5mg KwikPen® from 9 months to 14 months for the following batches : Product Batch No. Displayed/Printed Expiry Date New Expiry Date Dear Patient Letter link Mounjaro® 2.5mg KwikPen® [...]

The post Mounjaro®▼ (tirzepatide) 2.5 mg KwikPen® – shelf-life extension appeared first on Community Pharmacy England.